Adherence to anti-retroviral therapies not a problem in sub-Saharan lands.A review by a multi-national team of researchers (including Canadians) found that favourable levels of adherence to anti-retroviral therapy can be achieved in sub-Saharan African settings, but it also found that that adherence remains a concern in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. . The report appears in the Journal of The American Medical Association JAMA: The Journal of the American Medical Association is an international peer-reviewed general medical journal, published 48 times per year by the American Medical Association. JAMA is the most widely circulated medical journal in the world. , August 16, 2004. The study was undertaken because of concerns that adherence might be incomplete among patients living in poverty and might be a barrier in expanding the access to antiretroviral therapy in sub-Saharan Africa. Using research studies and data bases compiled in North American North American named after North America. North American blastomycosis see North American blastomycosis. North American cattle tick see boophilusannulatus. and sub-Saharan countries, the team focussed on general populations and avoided special groups, such as the homeless. They concluded that adherence to treatment adherence to treatment Compliance Therapeutics The following of a recommended course of treatment by taking all prescribed medications for the length of time necessary and drug routines was not a serious problem where the therapies were available in Africa. But adherence is more of a problem in North America. www.ama.ama-assn.org, |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion